Juhlin C - Search Results

1

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R. Nakagomi H, et al. Among authors: juhlin c. Cancer Res. 1993 Dec 1;53(23):5610-2. Cancer Res. 1993. PMID: 8242612

2

Expression of platelet-derived growth factor beta-receptors on stromal tissue cells in human carcinoid tumors.

Funa K, Papanicolaou V, Juhlin C, Rastad J, Akerström G, Heldin CH, Oberg K. Funa K, et al. Among authors: juhlin c. Cancer Res. 1990 Feb 1;50(3):748-53. Cancer Res. 1990. PMID: 2153446

3

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.

Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R. Nakagomi H, et al. Among authors: juhlin c. Int J Cancer. 1995 Nov 3;63(3):366-71. doi: 10.1002/ijc.2910630311. Int J Cancer. 1995. PMID: 7591233

4

Clinical and biochemical effects in vivo of monoclonal antitumor antibody in Verner-Morrison's syndrome.

Juhlin C, Papanicolaou V, Arnberg H, Klareskog L, Lörelius LE, Rastad J, Oberg K, Akerström G. Juhlin C, et al. Cancer. 1994 Mar 1;73(5):1346-52. doi: 10.1002/1097-0142(19940301)73:5<1346::aid-cncr2820730507>3.0.co;2-c. Cancer. 1994. PMID: 8111700 Clinical Trial.

5

Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas.

Yamamoto Y, Backlin K, Nakagomi H, Halapi E, Juhlin C, Bucht A, Kiessling R. Yamamoto Y, et al. Among authors: juhlin c. Cancer Immunol Immunother. 1993 Aug;37(3):163-8. doi: 10.1007/BF01525430. Cancer Immunol Immunother. 1993. PMID: 8334679 Free PMC article.

6

Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Halapi E, Yamamoto Y, Juhlin C, Jeddi-Tehrani M, Grunewald J, Andersson R, Hising C, Masucci G, Mellstedt H, Kiessling R. Halapi E, et al. Among authors: juhlin c. Cancer Immunol Immunother. 1993;36(3):191-7. doi: 10.1007/BF01741091. Cancer Immunol Immunother. 1993. PMID: 8439980 Free PMC article.

7

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.

Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A. Wennerberg E, et al. Among authors: juhlin cc. Clin Cancer Res. 2014 Nov 15;20(22):5733-44. doi: 10.1158/1078-0432.CCR-14-0291. Epub 2014 Sep 11. Clin Cancer Res. 2014. PMID: 25212604

8

P-glycoprotein expression and activity of resistance modifying agents in primary cultures of human renal and adrenocortical carcinoma cells.

Fridborg H, Larsson R, Juhlin C, Rastad J, Akerström G, Backlin K, Nygren P. Fridborg H, et al. Among authors: juhlin c. Anticancer Res. 1994 May-Jun;14(3A):1009-16. Anticancer Res. 1994. PMID: 7915506

9

Identification of a 35 kD tumor-associated autoantigen in papillary thyroid carcinoma.

Lucas SD, Ek B, Rask L, Rastad J, Akerström G, Juhlin C. Lucas SD, et al. Among authors: juhlin c. Anticancer Res. 1996 Sep-Oct;16(5A):2493-6. Anticancer Res. 1996. PMID: 8917340

10

Aberrantly expressed cytokeratin 1, a tumor-associated autoantigen in papillary thyroid carcinoma.

Lucas SD, Ek B, Rask L, Rastad J, Akerström G, Juhlin C. Lucas SD, et al. Among authors: juhlin c. Int J Cancer. 1997 Oct 9;73(2):171-7. doi: 10.1002/(sici)1097-0215(19971009)73:2<171::aid-ijc1>3.0.co;2-t. Int J Cancer. 1997. PMID: 9335437 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page